Appointment of Executive Director
2nd October 2018
Further to the announcement of the Interim Results on 19 September 2018, Cello Health plc (AIM: CLL), the global healthcare-focused advisory Group, is pleased to announce that Julia Ralston has been appointed Executive Director of the Company with immediate effect, bringing the executive team to a total of four. Julia’s presence on the Board will ensure appropriate levels of governance and control around Cello’s expanding US business.
Julia is CEO of Cello Health in the US, having joined the Group as CEO of MedErgy in 2011 following its acquisition by Cello. Julia is responsible for Cello’s strategic growth in the US and facilitating collaboration in the region across the Group’s capabilities in consulting, insight, and communications.